Furthermore, a genotype study performed by Goutas et al. (19) in sporadic MTC carcinoma cases reported that KRAS codon 12 mutations were found in 40.9% of the MTC cases, the BRAF V600E mutation in 68.2%. This evidence concerns the gene BRAF and medullary thyroid gland carcinoma.